Gilead CFO Andrew Dickinson Sells 3,000 Shares

What Happened Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences (GILD), reported an open-market sale of 3,000 shares on July 15, 2026. The filing shows the shares disposed at $129.93 for a reported total of $389,777. This was a sale (S) rather than a purchase; sales are often routine but do not by themselves indicate management sentiment.

Key Details

• Transaction date: July 15, 2026 (reported on Form 4 filed July 16, 2026)
• Reported price(s): $129.93 for the 3,000-share lot; footnote states sale prices ranged $129.45–$130.08 and that detailed per-price share breakdown is available on request (F2)
• Proceeds reported: $389,777 (per filing)
• Transaction type/code: Open-market sale (S)
• Plan disclosure: Executed under a pre-established Rule 10b5-1 trading plan adopted August 29, 2024 (F1)
• Shares owned after transaction: Not disclosed in the excerpt provided
• Filing timeliness: Filed the next day (appears timely; no late filing flag indicated)

Context A 10b5-1 plan lets insiders carry out pre-arranged trades at scheduled times, which can limit inference about short-term intent. For retail investors, purchases tend to be more informative than routine sales; this single small sale (3,000 shares) should be viewed in that context and not taken alone as a signal of company prospects.